| Treatment of Kounis syndrome. | |
| | |
MedLine Citation:
|
PMID: 20206392 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Kounis syndrome is potentially a life-threatening medical emergency with both a severe allergic reaction and acute coronary syndrome. Most of the information about this syndrome has come from the case reports. The management of these patients may be challenging for clinicians, and unfortunately guidelines have not been established yet. In this article, we review the current guidelines of acute coronary syndromes and anaphylaxis along with the published cases with Kounis syndrome secondary to beta-lactam antibiotics. We have summarized our recommendations for the work-up and treatment of Kounis syndrome from available data. Obviously, larger prospective studies are needed to establish definitive treatment guidelines for these patients. |
| | |
Authors:
|
Cihan Cevik; Kenneth Nugent; Goutam P Shome; Nicholas G Kounis |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-03-04 |
Journal Detail:
|
Title: International journal of cardiology Volume: 143 ISSN: 1874-1754 ISO Abbreviation: Int. J. Cardiol. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: 2010-12-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 223-6 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Texas Tech University Health Sciences Center, Department of Internal Medicine, Lubbock, TX 79430, United States. cihan.cevik@ttuhsc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Coronary Syndrome
/
drug therapy*,
etiology Anaphylaxis / drug therapy*, etiology Cardiovascular Agents / therapeutic use* Drug Hypersensitivity* Epinephrine / therapeutic use Histamine Antagonists / therapeutic use* Humans Immunosuppressive Agents / therapeutic use Practice Guidelines as Topic |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents; 0/Histamine Antagonists; 0/Immunosuppressive Agents; 51-43-4/Epinephrine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Informed consent and transesophageal echocardiography: a review of patient responses.
Next Document: Ironic effects and final target fixation in a penalty shooting task.